Skip to content

Inpatient Multidisciplinary Proactive Assessment for Comprehensive Treatment of Diabetes (IMPACT D) on Glycaemia and Glycaemic Complications in Inpatients with Diabetes

Inpatient Multidisciplinary Proactive Assessment for Comprehensive Treatment of Diabetes (IMPACT D) on Glycaemia and Glycaemic Complications in Inpatients with Diabetes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626001078347
Acronym
IMPACT D
Enrollment
4200
Registered
2026-09-01
Start date
2026-09-01
Completion date
2028-12-31
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To examine the effect of a dedicated proactive multidisciplinary team review on blood glucose control and associated complications from compared with usual care. It is hypothesised that this intervention will result in reduced incidence of hospital acquired infection and improved blood sugar control.

Interventions

The endocrinology consult service, diabetes educator and diabetes dietician will proactively instigate a bedside consult within 24 hours of randomisation (of inpatients with a single glucose reading above > 20mmol/L in the last 24 hours and/or two glucose readings > 15mmol/L in the preceding 24 hours). Endocrinology consults will involve discussions with patients regarding their current glycaemic management and strategies to improve their control, individualised for each patient. This may incl

The endocrinology consult service, diabetes educator and diabetes dietician will proactively instigate a bedside consult within 24 hours of randomisation (of inpatients with a single glucose reading above > 20mmol/L in the last 24 hours and/or two glucose readings > 15mmol/L in the preceding 24 hours). Endocrinology consults will involve discussions with patients regarding their current glycaemic management and strategies to improve their control, individualised for each patient. This may include education on what diabetes is and the rationale for good glycaemic control to prevent complications. Discussions regarding management will cover non-pharmacological and pharmacological options, how they work, and potential adverse effects to allow the patient to make an informed decision regarding changes or additions to therapy. such as the addition of insulin. The endocrinology consult service will also determine which patients should be reviewed by the diabetes nurse educators (DNE) and dieticians. DNEs will provide education tailored to the patient's current understanding. This may include education on different types of diabetes, how to monitor BGLs, manage hypoglycaemia, and injection technique for subcutaneous injections such as insulin. Dieticians will provide education on health diet and recommendations for the patient, particularly upon discharge. Frequency and duration of reviews will be determined by endocrinologist's clinical judgement based on patient glycaemic response. The duration of the first consult will likely range from 45-60 minutes. Subsequent reviews during the inpatient admission are expected to be shorter as they will involve review of BGLs and titration of medications such as insulin. The total duration of the intervention for each patient will be the duration of the inpatient period, or until the endocrinology consult service has made a clinical determination that there has been adequate improvement in glycaemic control prior to discharge. Electronic medical records will be reviewed to determine whether recommendations from the endocrinology consult service have been adhered to.

Sponsors

Central Adelaide Local Health Network (CALHN)
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

18 years of age Admitted to hospital at the Royal Adelaide Hospital or The Queen Elizabeth Hospital after 1 July 2026 Has received at least one blood glucose level (BGL) measurement that was recorded in the electronic medical record.

Exclusion criteria

Patients in the Intensive Care Unit or Palliative Care Unit or whose “home team” does not want diabetes team input

Outcome results

None listed

Source: ANZCTR · Data processed: Sep 19, 2026